Oruka Therapeutics, Inc. (ORKA) Financials

ORKA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 504.5 million 17.8 million
Dec. 31, 2025 488.6 million 16.7 million
Sept. 30, 2025 509.3 million 22.5 million
June 30, 2025 357.4 million 13.8 million

ORKA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -23.7 million 7.0 million
Dec. 31, 2025 -22.7 million 4.1 million
Sept. 30, 2025 -21.7 million 10.2 million
June 30, 2025 -23.2 million 5.1 million

ORKA Net Income

No data available :(

ORKA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 388.8 million - 1.1 million
Dec. 31, 2025 337.0 million - 1.3 million
Sept. 30, 2025 349.2 million - 1.5 million
June 30, 2025 328.4 million - 1.7 million

ORKA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 55.2 million
Dec. 31, 2025 54.4 million
Sept. 30, 2025 44.1 million
June 30, 2025 42.2 million

ORKA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 73000 29.1 million 7.2 million -
Dec. 31, 2025 63000 27.6 million 6.8 million -
Sept. 30, 2025 99000 29.0 million 5.1 million -
June 30, 2025 34000 24.1 million 4.3 million -

ORKA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 43000
Dec. 31, 2025 - 28000
Sept. 30, 2025 - -
June 30, 2025 - 19000

ORKA

Price: $68.86

52 week price:
10.77
91.00

Dividend Yield: 32.18%

Earnings Per Share: -1.93 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2.3 billion

Links: